References include the SURMOUNT-1 trial publication (Jastreboff et al., New England Journal of Medicine, 2022), the Mounjaro and Zepbound prescribing information (Eli Lilly, 2024), Liu et al., JAMA Internal Medicine, 2018 (steroid-induced hyperglycemia), and American Diabetes Association Standards of Care, 2024
This phosphorylation, which occurs via the JNK pathway, is considered to be crucial as it modifies FOXO4, preparing it for its role in the cells nucleus
SURMOUNT-4 showed that patients who lost weight on tirzepatide during a 36-week lead-in and then continued the drug maintained a further 5.5% reduction, while those switched to placebo regained 14.8% [13]
IV therapy, or intravenous therapy, delivers a custom blend of fluids, vitamins, minerals, and antioxidants directly into your bloodstream